Nuevos horizontes en la investigación del cáncer: del laboratorio al paciente CNIO Workshop on Philosophy & Biomedical Sciences: Debates on conceptual and social issues Heterogeneity and evolution in cancer

Inicio | Eventos | Understanding treatment resistance and the neuroendocrine phenotype in prostate cancer

Understanding treatment resistance and the neuroendocrine phenotype in prostate cancer

Información

Fecha: 26/09/2019
Hora 12:00
Lugar: CNIO Auditorium
Conferenciante Himisha Beltrán
Procedencia Dana Farber Cancer Institute, Boston, US
Invitado por David Olmos, Prostate Cancer Clinical Research Unit, Clinical Research Programme

Subir